Emil Martin
Papers
1
Total Citations
48
H-Index
1
About
Emil Martin is a leading researcher in nitric oxide (NO) and cyclic GMP (cGMP) signaling, with a primary focus on the molecular regulation of soluble guanylyl cyclase (sGC). His work has been instrumental in unraveling the complexity of sGC subunit composition and function, particularly through his landmark 2008 study on α1 sGC splice forms. This highly cited paper (48 citations) demonstrated that alternative splicing of the α1 subunit generates variant proteins capable of forming functional heterodimers with the β1 subunit, revealing a previously unrecognized layer of regulatory control over NO-dependent signaling. By identifying these splice forms as potential modulators of human sGC activity, Martin provided critical insights into how cells fine-tune their response to NO—a fundamental pathway underlying vasodilation, neurotransmission, and immune function. His contributions have deepened our understanding of sGC’s structural plasticity and opened new avenues for targeting this enzyme in cardiovascular and neurological diseases. Martin’s work continues to influence researchers exploring the therapeutic potential of NO/cGMP signaling, making him a key figure in this dynamic field.
Research Focus
Key Achievements
Top Papers
- 1